Targeted therapy for idiopathic pulmonary fibrosis: a bibliometric analysis of 2004–2024
BackgroundIdiopathic pulmonary fibrosis (IPF) is a progressive and irreversible interstitial lung disease characterized by high mortality rates. An expanding body of evidence highlights the critical role of targeted therapies in the management of IPF. Nevertheless, there is a paucity of bibliometric...
Saved in:
| Main Authors: | Xinlei Zhang, Zengze Yuan, Xiawei Shi, Junchao Yang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-03-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1543571/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A bibliometric analysis of research on idiopathic pulmonary fibrosis
by: ZENG Wei, et al.
Published: (2025-05-01) -
Composition and modification of the lung microbiome in patients with idiopathic pulmonary fibrosis
by: Victoria Maria Ruta, et al.
Published: (2020-10-01) -
Aging-associated interleukin-11 drives the molecular mechanism and targeted therapy of idiopathic pulmonary fibrosis
by: Jie Zhou, et al.
Published: (2025-07-01) -
Pulmonary fibrosis complicated by lung cancer: bibliometric analysis from 2004 to 2024 - research status, trends and future directions
by: Boyang Li, et al.
Published: (2025-04-01) -
IDIOPATHIC PULMONARY FIBROSIS. CORRECTION OF ERRORS
by: A. L. Yudin, et al.
Published: (2018-12-01)